BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces that the Data Safety Monitoring Board ...
FOBI AI Inc. announced that it has applied to its principal regulator, the British Columbia Securities Commission ("BCSC"), for a partial revocation order of the ongoing failure-to-file cease trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback